MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Unveiling the Molecular Mechanism of Polydatin in Ameliorating Parkinson’s Disease via the DRD2/CRYAB/NF-κB Axis in Astrocytes and Exploring Cell Therapy Strategies

    SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)

    Objective: Define polydatin's therapeutic mechanism targeting astrocyte-mediated neuroinflammation in Parkinson's disease (PD) and assess combinatorial efficacy with dopamine progenitor transplantation. Background: PD progression involves substantia…
  • 2025 International Congress

    Neural Correlates of Rhythmic Auditory Stimulation Responsiveness in Parkinson’s Disease: A Pilot Gait and fMRI Study

    CY. Chien, CL. Lin, JSK. Chang, YH. Liu, SC. Wang, CC. Lin (Tainan, Taiwan)

    Objective: To compare neural activity differences between Parkinson's disease patients responsive to rhythmic auditory stimulation (RAS-r) and those not responsive (RAS-n) using functional MRI (fMRI).…
  • 2025 International Congress

    Levodopa mediated normalization of cerebello-thalamo-cortical GABA and Glutamate in Parkinson’s disease

    S. Prasad, D. Deelchand, M. Kumar, R. Yadav, P. Pal, J. Saini (Bengaluru, India)

    Objective: This study aims to evaluate the effect of levodopa on cerebello-thalamo-cortical (CTC) gamma-aminobutyric acid (GABA) and glutamate in patients with Parkinson’s disease (PD) using…
  • 2025 International Congress

    Exploring the Association between Autonomic Responses and Dopaminergic Pathways in Early Parkinson’s Disease

    E. Garasto, A. Stefani, M. Pierantozzi, N. Mercuri, A. Chiaravalloti, C. Rocchi (Rome, Italy)

    Objective: To assess if cardiovascular dysautonomia, evaluated by autonomic function tests (AFTs), is related to dopaminergic nicgrostriatal loss and other non-motor symptoms in early Parkinson…
  • 2025 International Congress

    Genetic Correlations Between Parkinson’s Disease and Circulating Metabolites

    M. Tan, T. Ascencio, S. Rodriguez-Quiroga, J. Largo González, S. Peña Martinez, L. Hernandez Delgado, A. Noyce (San Salvador, El Salvador)

    Objective: To use genome-wide association studies (GWASs) to identify genetic correlations between Parkinson’s disease (PD) and circulating metabolites. Background: Metabolomics is the study of small…
  • 2025 International Congress

    Deep phenotyping of Parkinson‘s disease patients with the RAB32 Ser71Arg pathogenic variant and MDSGene literature review

    T. Kleinz, F. Cavallieri, M. Borsche, G. Toschi, F. Valzania, EM. Valente, P. Mitrotti, M. Avenali, S. Zittel, R. Born, M. Matarazzo, C. Shambetova, N. Griebner, L. Santinelli, M. Brand, C. Gabbert, A. Westenberger, J. Trinh, M. Radefeldt, C. Beetz, P. Bauer, N. Brüggemann, C. Klein (Reggio Emilia, Italy)

    Objective: To evaluate patients with PD and unaffected carriers of the pathogenic variant RAB32 p.Ser71Arg using a multimodal approach to gain insight into genotype-phenotype relationships…
  • 2025 International Congress

    Examining the Gut Microbiome in Parkinson Patients with GBA Mutations

    H. Dainton-Howard, A. Keshavarzian, A. Kirby, C. Goetz (Chicago, USA)

    Objective: Gut dysbiosis is implicated in Parkinson disease (PD) pathogenesis, but less is known about the interaction of PD associated gene variants and gut microbiota.…
  • 2025 International Congress

    Advancing Global Training and Capacity Building in Parkinson’s Genetics through GP2

    MT. Periñan, S. Dey, S. Finch, H. Leonard, M. Makarious, K. Atterling Brolin, A. Zirra, K. Step, V. van Midden, YW. Tay, Y. Mecheri, L. Faria-Costa, E. Fernandez-Toledo, V. Flores-Ocampo, C. Shambetova, A. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Sevilla, Spain)

    Objective: To promote and facilitate learning by providing resources and expertise to address the training needs of the Global Parkinson’s Genetics Program (GP2; www.gp2.org) and…
  • 2025 International Congress

    Rare Variants, Copy Number Variations, and Heritability Estimates in a Pilot Cohort of Egyptians with Parkinson’s Disease

    M. Yousef, A. El-Hosseiny, A. Nagano, A. Atputhavadivel, E. Khedr, M. William, A. Shalash, G. Fawy, S. El-Shafie, S. El-Jaafary, M. Koraym, Y. Salah, S. Elfarrash, Y. Elsaid, A. Gabr, N. Shebl, L. Aly, N. Abdelwahhab, T. Belal, N. Elsayed, M. El-Gamal, S. Elgamal, S. Ragab, J. Mekky, M. Salama, M. Rizig (Cairo, Egypt)

    Objective: To explore the genetic architecture of Parkinson's disease (PD) in Egypt, addressing the underrepresentation of this population in PD genetics research. Background: Genetic studies…
  • 2025 International Congress

    Delirium following deep brain stimulation: An 8 year single-centre study

    S. Farrand, T. Reilly, C. Monahan, G. Nair, J. Hannan, R. Blaze, M. Ghaly, K. Gomes, K. Hamilton, W. Lee, D. Thyagarajan, A. Gilligan, A. Evans (Melbourne, Australia)

    Objective: To describe the outcomes of patients undergoing deep brain stimulation (DBS) surgery for movement disorders and neuropsychiatric indications and characterise delirium symptoms. Background: Deep…
  • « Previous Page
  • 1
  • …
  • 89
  • 90
  • 91
  • 92
  • 93
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley